783132009: Bosentan hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Endothelin receptor antagonist\Bosentan hydrochloride

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Endothelin receptor antagonist\Bosentan hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3757781015 Bosentan hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3757782010 Bosentan hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bosentan hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Endothelin receptor antagonist (disposition)	true	Inferred relationship	Some
Bosentan hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Bosentan (substance)	true	Inferred relationship	Some
Bosentan hydrochloride	Is a	Endothelin receptor antagonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely bosentan (as bosentan hydrochloride) 62.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bosentan hydrochloride	Inferred relationship	Some	1
Product containing precisely bosentan (as bosentan hydrochloride) 125 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Bosentan hydrochloride	Inferred relationship	Some	1

This concept is not in any reference sets